1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Acne Treatment Market
4.
Executive Summary
5. Voice of Customer
6. Global Acne Treatment Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Therapeutic Class (Retinoids, Antibiotics, Hormonal
Drugs, Anti-Inflammatory Drugs, Chemical Peels and Others)
6.2.2. By Formulation (Topical Medications, Oral Medications and
Injectables)
6.2.3. By Type (Prescription Medicines and Over-The-Counter
Medicines)
6.2.4. By Acne Type (Cystic Acne, Postsurgical/Wound Acne, Comedonal
Acne, Inflammatory Acne)
6.2.5. By Distribution Channel (Hospitals, Retail Stores,
Pharmacies & Drug Stores, and E-Commerce)
6.2.6. By Company (2021)
6.2.7.
By Region (North America, Europe, Asia-Pacific, South America, Middle
East & Africa)
6.3.
Product Market Map
7. North America Acne Treatment Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Therapeutic Class
7.2.2.
By Formulation
7.2.3.
By Type
7.2.4.
By Acne Type
7.2.5.
By Distribution Channel
7.2.6.
By Country (United States; Canada; Mexico)
7.3.
North America: Country Analysis
7.3.1.
United States Acne Treatment Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Therapeutic Class
7.3.1.2.2.
By Formulation
7.3.1.2.3.
By Type
7.3.1.2.4.
By Acne Type
7.3.1.2.5.
By Distribution Channel
7.3.2.
Canada Acne Treatment Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Therapeutic Class
7.3.2.2.2.
By Formulation
7.3.2.2.3.
By Type
7.3.2.2.4.
By Acne Type
7.3.2.2.5.
By Distribution Channel
7.3.3.
Mexico Acne Treatment Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Therapeutic Class
7.3.3.2.2.
By Formulation
7.3.3.2.3.
By Type
7.3.3.2.4.
By Acne Type
7.3.3.2.5.
By Distribution Channel
8. Europe Acne Treatment Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Therapeutic Class
8.2.2.
By Formulation
8.2.3.
By Type
8.2.4.
By Acne Type
8.2.5.
By Distribution Channel
8.2.6.
By Country (France; Germany; UK; Italy; Spain)
8.3.
Europe: Country Analysis
8.3.1.
France Acne Treatment Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Therapeutic Class
8.3.1.2.2.
By Formulation
8.3.1.2.3.
By Type
8.3.1.2.4.
By Acne Type
8.3.1.2.5.
By Distribution Channel
8.3.2.
Germany Acne Treatment Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Therapeutic Class
8.3.2.2.2.
By Formulation
8.3.2.2.3.
By Type
8.3.2.2.4.
By Acne Type
8.3.2.2.5.
By Distribution Channel
8.3.3.
United Kingdom Acne Treatment Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Therapeutic Class
8.3.3.2.2.
By Formulation
8.3.3.2.3.
By Type
8.3.3.2.4.
By Acne Type
8.3.3.2.5.
By Distribution Channel
8.3.4.
Italy Acne Treatment Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Therapeutic Class
8.3.4.2.2.
By Formulation
8.3.4.2.3.
By Type
8.3.4.2.4.
By Acne Type
8.3.4.2.5.
By Distribution Channel
8.3.5.
Spain Acne Treatment Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Therapeutic Class
8.3.5.2.2.
By Formulation
8.3.5.2.3.
By Type
8.3.5.2.4.
By Acne Type
8.3.5.2.5.
By Distribution Channel
9. Asia-Pacific Acne Treatment Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1.
By Therapeutic Class
9.2.2.
By Formulation
9.2.3.
By Type
9.2.4.
By Acne Type
9.2.5.
By Distribution Channel
9.2.6. By Country (China; India; Japan; South Korea; Australia)
9.3.
Asia-Pacific: Country Analysis
9.3.1.
China Acne Treatment Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Therapeutic Class
9.3.1.2.2.
By Formulation
9.3.1.2.3.
By Type
9.3.1.2.4.
By Acne Type
9.3.1.2.5.
By Distribution Channel
9.3.2.
India Acne Treatment Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Therapeutic Class
9.3.2.2.2.
By Formulation
9.3.2.2.3.
By Type
9.3.2.2.4.
By Acne Type
9.3.2.2.5.
By Distribution Channel
9.3.3.
Japan Acne Treatment Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Therapeutic Class
9.3.3.2.2.
By Formulation
9.3.3.2.3.
By Type
9.3.3.2.4.
By Acne Type
9.3.3.2.5.
By Distribution Channel
9.3.4.
South Korea Acne Treatment Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Therapeutic Class
9.3.4.2.2.
By Formulation
9.3.4.2.3.
By Type
9.3.4.2.4.
By Acne Type
9.3.4.2.5.
By Distribution Channel
9.3.5.
Australia Acne Treatment Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Therapeutic Class
9.3.5.2.2.
By Formulation
9.3.5.2.3.
By Type
9.3.5.2.4.
By Acne Type
9.3.5.2.5.
By Distribution Channel
10. Middle East and
Africa Acne Treatment Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Therapeutic Class
10.2.2.
By Formulation
10.2.3.
By Type
10.2.4.
By Acne Type
10.2.5.
By Distribution Channel
10.2.6.
By Country (UAE; Saudi Arabia; South Africa)
10.3.
MEA: Country Analysis
10.3.1.
South Africa Acne Treatment Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Therapeutic Class
10.3.1.2.2.
By Formulation
10.3.1.2.3.
By Type
10.3.1.2.4.
By Acne Type
10.3.1.2.5.
By Distribution Channel
10.3.2.
Saudi Arabia Acne Treatment Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Therapeutic Class
10.3.2.2.2.
By Formulation
10.3.2.2.3.
By Type
10.3.2.2.4.
By Acne Type
10.3.2.2.5.
By Distribution Channel
10.3.3.
UAE Acne Treatment Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Therapeutic Class
10.3.3.2.2.
By Formulation
10.3.3.2.3.
By Type
10.3.3.2.4.
By Acne Type
10.3.3.2.5.
By Distribution Channel
11. South America Acne Treatment Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Therapeutic Class
11.2.2.
By Formulation
11.2.3.
By Type
11.2.4.
By Acne Type
11.2.5.
By Distribution Channel
11.2.6.
By Country (Brazil; Argentina; Colombia)
11.3.
South America: Country Analysis
11.3.1.
Brazil Acne Treatment Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Therapeutic Class
11.3.1.2.2.
By Formulation
11.3.1.2.3.
By Type
11.3.1.2.4.
By Acne Type
11.3.1.2.5.
By Distribution Channel
11.3.2.
Argentina Acne Treatment Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Therapeutic Class
11.3.2.2.2.
By Formulation
11.3.2.2.3.
By Type
11.3.2.2.4.
By Acne Type
11.3.2.2.5.
By Distribution Channel
11.3.3.
Colombia Acne Treatment Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Therapeutic Class
11.3.3.2.2.
By Formulation
11.3.3.2.3.
By Type
11.3.3.2.4.
By Acne Type
11.3.3.2.5.
By Distribution Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
Competition Outlook
14.2.
Global Players Profiled (Leading Companies)
14.2.1. Novan Inc.
14.2.2. Vyome Biosciences Pvt. Ltd.
14.2.3. Foamix Pharmaceuticals Ltd.
14.2.4. BioPharmX Corporation
14.2.5. Paratek Pharmaceuticals, Inc.
14.2.6. Sun Pharmaceuticals Ltd.
14.2.7. Hegde & Hegde Pharmaceutica LLP
14.2.8. Mankind Pharmaceuticals Ltd.
14.2.9. Cipla Ltd.
14.2.10.
Glenmark Pharmaceuticals Limited
14.2.11.
Stiefel Laboratories Inc.
14.2.12.
Galderma S.A.
14.2.13.
Lumenis Ltd.
14.2.14.
Cutera, Inc.
14.2.15.
Alma
Lasers Ltd.
15. Strategic
Recommendations